AIM - Artificial Intelligence in Medicine

01/06/2021

😷According to Worldometers.info, as of June 1, there were 171,472,509 coronavirus cases worldwide, resulting in 3,565,243 deaths. It seems that thorough vaccination is the best way to stop the pandemic and help us return to everyday life.

👉Read more on COVID-19 vaccines: https://bit.ly/3uBF7NN

26/05/2021

😷📈SPRING 2021 SPIKE IN COVID-19 CASES

This spring, India is facing a sudden spike in coronavirus cases. While the increase is also seen in other countries, it is currently highest in India. What was the cause?

👉Read more: https://covid19-help.org/blog/the-covid-19-pandemic-what-is-happening-in-india

India has been fighting a massive wave of COVID-19 infection. What is the situation like right now? Is a novel coronavirus variant to blame? And what does it mean for the rest of the world? 

13/05/2021

⚕️😷ANTIBODY-BASED THERAPY

has great potential for those already infected with SARS-CoV-2. Several antibody-based therapies have received emergency use authorization by FDA. What are they, and what is their efficiency?

Read more: https://covid19-help.org/blog/antibody-therapy-of-covid-19

@

Antibody-based therapy has great potential for those already infected with SARS-CoV-2.

09/05/2021

💉🧒According to BCC, Canada authorizes Pfizer vaccine for children aged 12 to 15.

🍁Canada is the first country to do so for this age group. The province of Alberta with the highest rate of the virus said it would offer vaccines to those over 12 from Monday, May 10.

It's the first country to allow the Pfizer jab for this age group.

07/05/2021

🙌BREAKING NEWS

Early trial data shows that the third dose of Moderna vaccine increases antibodies against 😷COVID-19 variants found in Brazil and South Africa. The booster shots also boost antibodies against the original version of COVID-19.

Moderna Inc (MRNA.O) said on Wednesday early human trial data shows that a third dose of either its current COVID-19 shot or an experimental new vaccine candidate increases immunity against variants of COVID-19 first found in Brazil and South Africa.

28/04/2021

❓WAS SARS-CoV-2 MANMADE?🤔

As with any major event these days, the coronavirus pandemic also has its share of conspiracy theories on what „really“ happened. What do the genetic data tell us about the origin of SARS-CoV-2?

Read more: https://bit.ly/32P2Leo

20/04/2021

❓HOW CAN ARTIFICIAL INTELLIGENCE HELP FIGHT 😷COVID-19?

You can use it in combination with geographical information for monitoring and predicting outbreaks, in an app in form of a digital assistant for disease screening, for monitoring the sentiment of social media posts, or for processing research papers to find potential treatment for COVID-19.

You can learn more about projects presented at the webinar Fighting COVID-19 with Open Science here:
https://www.eoscsecretariat.eu/events/co-creating-eosc-webinars-fighting-covid-19-open-science

14/04/2021

THE POTENTIAL OF STEM CELL THERAPY FOR COVID-19

In severe COVID-19 cases, cytokines are released hyper-actively, which causes a cytokine storm leading to acute respiratory distress syndrome (ARDS). Stem cell therapy, specifically mesenchymal stem cells (MSCs), could inhibit the immune system's exaggerated response in COVID-19 patients.

Read more: https://covid19-help.org/blog/the-potential-of-stem-cell-therapy-for-covid-19

06/04/2021

The past year has seen an unprecedented pandemic spread quickly around the globe, but it has also witnessed the rise of an unprecedented scientific response, with vaccines approved within a year. Scientific research has been essential to combating this crisis, research which has been facilitated by the FAIR data and Open Science practices also promoted by the European Open Science Cloud (EOSCsecretariat).

Register for the free webinar “Co-creating EOSC Webinars: Fighting COVID-19 with Open Science” and learn more about three of the EOSC COVID-19 co-creation projects (including Project COVID19-help.org): https://bit.ly/2PbUiip

01/04/2021

🤔IS IT SAFE TO VACCINATE ADOLESCENTS?

Yesterday, Pfizer/BioNTech announced positive topline results of pivotal COVID-19 vaccine study in adolescents. In participants aged 12-15 years old, BNT162b2 demonstrated 100% efficacy and robust antibody responses, exceeding those reported in the trial of vaccinated 16-25-year-old participants in an earlier analysis, and was well tolerated.

Pfizer vaccine details https://covid19-help.org/substance/bnt162b2

31/03/2021

🌦️It is difficult to see any bright side of the coronavirus pandemic. But there might be some positive outcomes, as COVID-19 has helped to speed up some exciting medical innovations.

Read more: https://covid19-help.org/blog/medical-innovations-boosted-by-the-covid-19-pandemic

23/03/2021

😷 BREAKING NEWS

Phase 3 trial shows REGEN-COV™ (casirivimab with imdevimab) antibody cocktail reduced hospitalization or death by 70% in non-hospitalized COVID-19 patients.

More info on REGEN-COV https://covid19-help.org/substance/regen-cov